Die meistzitierten Artikel
|
Rang |
Autoren |
Paper |
Zitierungen |
1 | Zinman, B;...; [+ 11 Koautoren, darunter 6 aus D, z.B. Woerle, HJ, Brödl, UC] | Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes N ENGL J MED 373(22): 2117-28 (26 NOV 2015) | 2592 |
2 | Marso, SP;...; Mann, JFE; Nauck, MA;...; Buse, JB | Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes N ENGL J MED 375(4): 311-22 (28 JUL 2016) | 1769 |
3 | Scirica, BM;...; [+ 889 Koautoren, darunter 11 aus D] | Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus N ENGL J MED 369(14): 1317-26 (3 OCT 2013) | 1717 |
4 | Speliotes, EK;...; [+ 374 Koautoren, darunter zahlreiche aus D, z.B. Illig, T; Bornstein, SR] | Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index NAT GENET 42(11): 937-48 (NOV 2010) | 1701 |
5 | Yao, JC;...; Pavel, ME;...; Oberg, K | Everolimus for Advanced Pancreatic Neuroendocrine Tumors N ENGL J MED 364(6): 514-23 (10 FEB 2011) | 1550 |
6 | Baselga, J;...; Gnant, M;...; Vittori, L;...; Hortobagyi, GN | Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer N ENGL J MED 366(6): 520-9 (9 FEB 2012) | 1496 |
7 | Sarwar, N;...; Meisinger, C.;...; Danesh, J | Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies LANCET 375(9733): 2215-22 (JUN-JUL 2010) | 1453 |
8 | Ryan, CJ;...; Suttmann, H;...; Rathkopf, DE | Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy N ENGL J MED 368(2): 138-48 (10 JAN 2013) | 1365 |
9 | Raymond, E;...; Hörsch, D;...; Wiedenmann, B;...; Ruszniewski, P | Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors N ENGL J MED 364(6): 501-13 (10 FEB 2011) | 1305 |
10 | Zeggini, E;...; Grallert, H;...; Herder, C;...; Meisinger, C;...; Illig, T;...; Altshuler, D | Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes NAT GENET 40(5): 638-45 (MAY 2008) | 1293 |